(S1 (S (NP (NP (NP (NNS Insights)) (PP (IN into) (NP (NP (DT the) (NN Regulation)) (PP (IN of) (NP (NN TNF-alpha) (NN Production))) (PP (IN in) (NP (JJ Human) (JJ Mononuclear) (NNS Cells)))))) (: :) (NP (NP (DT The) (NNS Effects)) (PP (IN of) (NP (JJ Non-Specific) (NN Phosphodiesterase) (NN Inhibition)))))))
(S1 (S (NP (NN OBJECTIVE))))
(S1 (S (S (NP (NP (DT The) (NN objective)) (PP (IN of) (NP (DT this) (NN study)))) (VP (VBD was) (S (VP (TO to) (VP (VB determine) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ nonspecific) (NN phosphodiesterase) (NN inhibition))) (PP (IN on) (NP (NP (NP (NN transcription) (NN factor) (NN activation)) (CC and) (NP (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (NN production))) (PP (IN in) (NP (ADJP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -stimulated)) (JJ human) (JJ mononuclear) (NNS cells))))))))))) (. .)))
(S1 (S (NP (NN INTRODUCTION))))
(S1 (S (S (NP (NP (DT The) (NN production)) (PP (IN of) (NP (NN TNF-alpha))) (PP (VBG following) (NP (NN LPS) (NN stimulation)))) (VP (VBZ is) (NP (NP (CD one)) (PP (IN of) (NP (NP (DT the) (JJ key) (NNS steps)) (PP (IN in) (NP (NP (JJ bacterial) (NN sepsis)) (CC and) (NP (NN inflammation))))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (NN mechanism)) (SBAR (WHPP (IN by) (WHNP (WDT which))) (S (NP (NN phosphodiesterase) (NN inhibition)) (VP (VBZ alters) (NP (NN TNF-alpha) (NN production)) (PP (IN in) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (NN LPS))))))))) (VP (VBZ remains) (ADJP (JJ unclear)))) (. .)))
(S1 (S (NP (NNS METHODS))))
(S1 (S (S (NP (JJ Human) (JJ mononuclear) (NNS cells)) (VP (VBD were) (VP (VBN stimulated) (PP (IN with) (NP (NP (NN LPS)) (PRN (-LRB- -LRB-) (NP (CD 1) (NN mug/mL)) (-RRB- -RRB-)))) (, ,) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC and) (NP (NN absence))) (PP (IN of) (NP (NP (NP (NN Pentoxifylline)) (PRN (-LRB- -LRB-) (NP (NP (NN PTX)) (: ;) (NP (CD 20) (NN mM))) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ nonspecific) (NN phosphodiesterase) (NN inhibitor))))))))) (. .)))
(S1 (S (S (NP (NP (NN Western) (NN blotting)) (PP (IN of) (NP (NP (JJ phosphorylated) (JJ cytoplasmic) (NN I-kappaBalpha)) (, ,) (NP (NP (NP (JJ nuclear) (NN factor-kappaB)) (NN p65)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NP (JJ nuclear) (JJ cAMP-response) (NN element) (NN binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN CREB)) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VBN performed)))) (. .)))
(S1 (S (S (NP (NP (NN DNA) (NN binding)) (PP (IN of) (NP (NP (NN NF-kappaB)) (CC and) (NP (NN CREB))))) (VP (VBD was) (VP (VBN verified) (PP (IN by) (NP (JJ electrophoretic) (NN mobility) (NN shift) (NN assay)))))) (. .)))
(S1 (S (S (NP (NN TNF-alpha) (NNS levels)) (VP (VBD were) (VP (VBN determined) (PP (IN in) (NP (NP (DT the) (NN supernatant)) (PP (IN of) (NP (NP (VBN stimulated) (NNS cells)) (PP (IN in) (NP (NP (DT the) (NP (NN presence)) (CC and) (NP (NN absence)) (NP (NN Protein) (NN kinase) (NN A) (NN inhibition))) (PP (IN by) (NP (NP (DT an) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (PRN (-LRB- -LRB-) (NP (NN ELISA)) (-RRB- -RRB-))))))))))))) (. .)))
(S1 (S (NP (NNS RESULTS))))
(S1 (S (S (NP (NN PTX)) (VP (VBD was) (VP (VBN demonstrated) (S (VP (TO to) (ADVP (RB significantly)) (VP (VB reduce) (NP (NP (JJ cytoplasmic) (NN I-kappaBalpha) (NN phosphorylation)) (, ,) (NP (JJ nuclear) (NN p65) (NN phosphorylation)) (, ,) (CC and) (NP (NP (DT the) (NN DNA) (NN binding) (NN activity)) (PP (IN of) (NP (NN NF-kappaB))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NN PTX)) (ADVP (RB markedly)) (VP (VBD enhanced) (NP (NP (DT the) (NP (NN phosphorylation)) (CC and) (NP (NN DNA) (NN binding) (NN activity))) (PP (IN of) (NP (NN CREB)))))) (. .)))
(S1 (S (S (NP (NP (NNS Cells)) (VP (ADVP (RB concomitantly)) (VBN treated) (PP (IN with) (NP (NP (NN PTX)) (CC and) (NP (NN LPS)))))) (VP (VBN secreted) (NP (NP (JJ similar) (NNS levels)) (PP (IN of) (NP (NN TNF-alpha)))) (PP (IN in) (NP (DT the) (NP (NN presence)) (CC and) (NP (NN absence)) (NP (NN Protein) (NN kinase) (NN A) (NN inhibition)))))) (. .)))
(S1 (S (NP (NN DISCUSSION))))
(S1 (S (S (NP (NP (DT The) (VBN increased) (NN level)) (PP (IN of) (NP (NN cAMP))) (SBAR (WHNP (WDT that)) (S (VP (VBZ results) (PP (IN from) (NP (NN phosphodiesterase) (NN inhibition))))))) (VP (VBZ affects) (NP (ADJP (ADJP (JJ cytoplasmic)) (CC and) (ADJP (JJ nuclear))) (NNS events)) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT the) (NN attenuation)) (PP (IN of) (NP (NP (NN NF-kappaB)) (CC and) (NP (NP (DT the) (NN activation)) (PP (IN of) (NP (NN CREB)))) (NP (JJ transcriptional) (NN DNA) (NN binding)))))) (PP (IN through) (NP (NP (NNS pathways)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (ADVP (RB partially)) (ADJP (NN Protein) (NN kinase) (JJ A-independent))))))))))) (. .)))
(S1 (S (NP (NN CONCLUSION))))
(S1 (S (S (NP (JJ PTX-mediated) (NN phosphodiesterase) (NN inhibition)) (VP (VP (VBZ occurs) (ADVP (RB partially)) (PP (IN through) (NP (DT a) (ADJP (NN Protein) (NN kinase) (JJ A-independent)) (NN pathway)))) (CC and) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (JJ useful) (NN tool)) (PP (IN in) (NP (NP (DT the) (NN attenuation)) (PP (IN of) (NP (JJ LPS-induced) (NN inflammation))))))))))) (. .)))
